Kyowa Kirin 3Q pharma sales up despite Nesp dip
This article was originally published in Scrip
Executive Summary
Japan's Kyowa Hakko Kirin saw net pharmaceutical sales edge up by 2% to JPY192.7bn ($1.98bn) in the nine months ended 30 September, despite the lackluster performance of its mainstay product.